- Site Map
- Privacy
- Published by:Zoomedia, Inc.
Join our Mailing List
Published by Zoomedia, Inc.
Zoomedia is a leading communications agency dedicated to increasing our clients' value through insightful and imaginative creative programs for the life sciences industry.
For questions or comments about this site, please contact MayBac@zoomedia.com.
©2008 Zoomedia, Inc.
All rights reserved.
Affymetrix, Inc
| Affymetrix’ GeneChip® technology was invented in the late 1980’s by a team of scientists led by Stephen P.A. Fodor, Ph.D. The theory behind their work was revolutionary - a notion that semiconductor manufacturing techniques could be united with advances in combinatorial chemistry to build vast amounts of biological data on a small glass chip. This technology became the basis of a new company, Affymetrix, formed as a division of Affymax, N.V. in 1991. Affymetrix began operating independently in 1992. | Center Map | ||
| |||
Anesiva, Inc.
| Anesiva, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for pain management. | Center Map | ||
| |||
Applied Biosystems
| Applied Biosystems has demonstrated its position as a technology leader and driving force in the changing dynamics of the life science marketplace. The Applied Biosystems business is focused on the following markets: basic research, commercial research (pharmaceutical and biotechnology) and standardized testing, including forensic human identification, paternity testing and food testing. The company has an installed base of approximately 180,000 instrument systems in nearly 100 countries. | Center Map | ||
| |||
Baxter BioScience Corporation
| Baxter International Inc. is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. With 2006 sales of $10.4 billion, and approximately 45,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients’ lives. | Center Map | ||
| |||
BayBio (Bay Area Bioscience Association)
| BayBio is an independent, non-profit 501(c)(6) trade association serving the life science industry in Northern California. The staff and services of BayBio are paid primarily through memberships, sponsorships, and event registration fees. BayBio provides these services through representatives in South San Francisco and through coalition partners in Washington, DC. Through advocacy, membership services, programs and more, BayBio brings the world's greatest life science community to your fingertips. With the support of more than 400 member organizations, BayBio is delivering the next-generation association to you today. | Center Map | ||
| |||
Bayer Corp Pharmaceuticals
| Through breakthroughs in research, great products and clear dedication, Bayer strives to improve lives in hundreds of ways, both big and small. | Center Map | ||
| |||
Bio-Rad Laboratories, Inc.
| Bio-Rad Laboratories has remained at the center of scientific discovery for more than 50 years by providing a broad range of innovative tools and services to the clinical diagnostics and life science research markets. The company is world renowned among hospitals, universities, major research institutions, biotechnology and pharmaceutical firms for its commitment to quality and customer service. It has built strong customer relationships that advance research and development efforts and support the commercialization of new technology, especially in the high-growth fields of genomics, proteomics, biopharmaceutical discovery, food safety and biotechnology education. | Center Map | ||
| |||
BioMarin Pharmaceutical Inc.
| BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that: address currently unmet medical needs, suggest a clear-cut development profile, provide an opportunity to be first-to-market. | Center Map | ||
| |||
Cell Genesys, Inc.
| Cell Genesys is focused on the development and commercialization of biological therapies for patients with cancer. | Center Map | ||
| |||
ChemoCentryx, Inc.
| ChemoCentryx is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics for autoimmune diseases, inflammatory disorders and cancer. | Center Map | ||
| |||
Chiron, Inc.
| Preventing tranfusion-transmitted infection is what Chiron is all about. As the world leader in blood safety for the transfusion industry, we develop novel tools, products and services to protect the global blood supply. Chiron is the blood screening business of Novartis Vaccines and Diagnostics, a division of Novartis AG that was created in 2006 following the acquisition of Novartis Vaccines and Diagnostics. | Center Map | ||
| |||
Dey LP
| Dey is a specialty pharmaceutical company focused on developing, manufacturing and marketing novel drug delivery technology for the treatment of respiratory diseases. As a recognized leader in respiratory care, DEY is best known as one of the largest US manufacturers of sterile, unit-dose inhalation solution products. | Center Map | ||
| |||
Exelixis, Inc.
| At Exelixis, we are committed to making a meaningful impact on the lives of patients living with cancer. We are advancing an ambitious and pragmatic approach to drug development, to develop first-in-class and best-in-class therapies that will transform the treatment of cancer. | Center Map | ||
| |||
Genencor International, Inc.
| Genencor delivers over 250 diverse products to customers around the world. | Center Map | ||
| |||
Genentech, Inc.
| Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. | Center Map | ||
| |||
Gilead Sciences, Inc.
| Gilead’s primary areas of focus include: antivirals (such as HIV/AIDS and chronic hepatitis), cardiovascular conditions (such as pulmonary arterial hypertension and resistant hypertension) and respiratory diseases (such as influenza and cystic fibrosis). | Center Map | ||||||
| |||||||
InterMune, Inc.
| InterMune is a biopharmaceutical company focused on developing and commercializing innovative therapies in pulmonology and hepatology. | Center Map | ||
| |||
MAP Pharmaceuticals, Inc.
| MAP Pharmaceuticals uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. | Center Map | ||
| |||
MedImmune Vaccines, Inc.
| MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. | Center Map | ||
| |||
Medivation, Inc.
| Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively. We have leveraged the knowledge and skills of our seasoned team to create a portfolio of therapies with the potential to revolutionize medical practice. Our current product pipeline consists of small-molecule drugs in clinical development to treat three large, unmet medical needs—Alzheimer’s disease, Huntington’s disease and hormone-refractory prostate cancer. | Center Map | ||
| |||
Merck & Co., Inc.
| Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. | Center Map | ||
| |||
Nektar Therapeutics
| Nektar is a biopharmaceutical company with a different approach to medicine. We develop drugs that are easier to take, safer to use, longer lasting and more effective. We look closely at existing therapies, and leverage our knowledge and extensive development expertise to evaluate how they can more effectively impact patients’ lives. | Center Map | ||
| |||
Novacea, Inc.
| At Novacea, we are fully committed to the belief that We Can™ succeed in our efforts to in-license, develop, and commercialize therapies that can potentially provide paradigm shifts in the treatment of a broad number of cancers. | Center Map | ||
| |||
Novo Nordisk Delivery Technologies, Inc.
| Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. | Center Map | ||
| |||
Nuvelo, Inc.
| Nuvelo, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. | Center Map | ||
| |||
PDL BioPharma, Inc.
| PDL BioPharma is a leader in the discovery, development, manufacturing and marketing of innovative therapies for serious or life-threatening illnesses, commercially focused on the acute- care, hospital based setting. Our therapeutic emphasis is on the areas of inflammation and autoimmune diseases, cardiovascular disorders and cancer. | Center Map | ||
| |||
Poniard Pharmaceuticals, Inc.
| Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. | Center Map | ||
| |||
Raven Biotechnologies, Inc.
| Raven biotechnologies, inc. is focused on the discovery of new drug targets for life-threatening conditions and the development of antibody therapeutic products to treat them. | Center Map | ||
| |||
Roche Molecular Systems, Inc.
| Roche Diagnostics offers a broad range of innovative diagnostic tests and systems that play a pivotal role in the groundbreaking area of integrated healthcare solutions. Our products cover the early detection, targeted screening, evaluation and monitoring of the disease. | Center Map | ||
| |||
Roche Palo Alto
| Roche is a leading healthcare company with a uniquely broad spectrum of innovative solutions. For more than 100 years, we have been active in the discovery, development, manufacture and marketing of novel healthcare solutions. Our products and services address prevention, diagnosis and treatment of diseases, thus enhancing well-being and quality of life. | Center Map | ||
| |||
Santen, Inc.
| Santen Incorporated, a wholly owned subsidiary of Santen Pharmaceutical Co., Ltd., opened its doors in the San Francisco Bay Area in 1993. Located in Northern California’s Napa Valley, the U.S. office is comprised of established, highly experienced healthcare professionals, led by President and CEO, Adrienne Graves, PhD. | Center Map | ||
| |||
Solstice Neurosciences, Inc.
| Solstice Neurosciences, Inc. is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice’s first product, Myobloc®/NeuroBloc® (Botulinum Toxin Type B) Injectable Solution, represents the only botulinum toxin type B currently available to physicians and patients worldwide. | Center Map | ||
| |||
Tercica, Inc.
| Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to develop and commercialize therapeutics for growth and other endocrine disorders. | Center Map | ||
| |||
XDx, Inc.
| Founded in 2000, XDx is a molecular diagnostics company based in Brisbane, Calif. Setting the stage for a new era in personalized medicine, XDx is one of the first companies to develop and commercialize practical applications built on insights from the Human Genome Project. The company has developed a proprietary new method for noninvasively monitoring the immune system by measuring gene expression in a patient’s peripheral blood. The technology offers the potential to decrease healthcare costs and significantly improve the quality of life for patients with a variety of life-threatening or life-altering, immune-mediated diseases. | Center Map | ||
| |||
XOMA, LLC
| XOMA is a leader in the discovery, development and manufacture of therapeutic antibodies. XOMA’s exceptionally broad technology platform, leading scientific expertise, and fully integrated product development infrastructure, extends from antibody discovery to regulatory approval. | Center Map | ||
| |||
Zoomedia, Inc.
| Zoomedia provides life science clients with a full range of communications and marketing services, from analysis through strategic planning, implementation, and production. We accelerate client success through intelligent communication initiatives that directly support business goals. | Center Map | ||||
| |||||
